Cytogem Injection 200 mg/5.26 ml contains Gemcitabine, a potent chemotherapeutic agent widely used in the treatment of various solid tumors. Gemcitabine belongs to the class of antimetabolite drugs, which interfere with DNA synthesis and inhibit cancer cell growth. Cytogem is formulated for intravenous administration and is primarily used in hospitals and oncology centers under strict medical supervision.

Gemcitabine is indicated for the treatment of several cancers, including pancreatic, non-small cell lung, breast, and ovarian cancers. It may be used as a single agent or in combination with other chemotherapy drugs depending on the type and stage of cancer. The injection provides a precise dosage and allows for flexible administration schedules according to the patient’s treatment plan.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Gemcitabine is a nucleoside analog that mimics deoxycytidine, a natural building block of DNA. Once inside cancer cells, it is phosphorylated to its active triphosphate form. This active form incorporates into the DNA during replication, causing premature termination of the DNA chain.

Additionally, Gemcitabine inhibits ribonucleotide reductase, an enzyme critical for the production of deoxyribonucleotides needed for DNA synthesis. The combination of these actions leads to the death of rapidly dividing cancer cells while sparing most normal cells, which divide at a slower rate.

Indications

Cytogem Injection 200 mg/5.26 ml is commonly prescribed for:

• Pancreatic cancer (advanced or metastatic)

• Non-small cell lung cancer (NSCLC)

• Breast cancer

• Ovarian cancer

• Treatment in combination with other chemotherapeutic agents for enhanced efficacy

It is particularly effective in cancers that demonstrate rapid cell proliferation and is a key component in several standard chemotherapy regimens.

Dosage and Administration

The dose of Cytogem Injection depends on the patient’s body surface area, type of cancer, and whether it is used as monotherapy or in combination therapy. It is administered intravenously over a set period, typically once weekly for several weeks, with rest periods in between cycles to allow healthy cells to recover.

Patients must be closely monitored during and after infusion for blood cell counts, liver and kidney function, and overall tolerance. Dosage adjustments may be necessary in patients with pre-existing organ dysfunction or severe side effects.

Precautions and Warnings

• Use only under professional supervision in a clinical setting.

• Inform your physician if you have liver or kidney disease, infections, or a history of low blood counts.

• Gemcitabine may cause fetal harm; pregnancy should be avoided during treatment.

• Patients should practice infection prevention measures, as the drug can reduce immune function.

• Healthcare professionals must handle the drug with care, using protective equipment due to its cytotoxic nature.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Nausea and vomiting

• Fatigue and weakness

• Low blood counts (anemia, neutropenia, thrombocytopenia)

• Fever or infection

• Rash or flu-like symptoms

• Rarely, liver or kidney dysfunction

Supportive care, hydration, and monitoring help manage side effects during treatment.

Storage Instructions

Store Cytogem Injection 200 mg/5.26 ml in a cool, dry place, protected from light. Keep out of reach of children. Reconstituted solutions should be prepared and administered immediately following hospital protocols.

Cytogem Injection 200 mg/5.26 ml is a critical chemotherapy agent, providing targeted antitumor activity for a range of solid cancers while offering flexibility for individualized treatment plans.